BARICORDI, Olavio
 Distribuzione geografica
Continente #
NA - Nord America 11.586
AS - Asia 6.731
EU - Europa 5.945
SA - Sud America 965
AF - Africa 149
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.397
Nazione #
US - Stati Uniti d'America 11.350
IT - Italia 2.674
SG - Singapore 2.374
CN - Cina 2.068
DE - Germania 823
BR - Brasile 763
UA - Ucraina 728
VN - Vietnam 690
HK - Hong Kong 500
TR - Turchia 381
GB - Regno Unito 364
FI - Finlandia 343
FR - Francia 235
RU - Federazione Russa 193
JP - Giappone 152
IN - India 148
SE - Svezia 134
PL - Polonia 114
CA - Canada 112
NL - Olanda 110
MX - Messico 85
BD - Bangladesh 71
AR - Argentina 62
ZA - Sudafrica 53
IQ - Iraq 51
ID - Indonesia 49
AT - Austria 42
EC - Ecuador 39
ES - Italia 32
CO - Colombia 30
TH - Thailandia 30
BE - Belgio 29
UZ - Uzbekistan 28
PK - Pakistan 27
MA - Marocco 26
VE - Venezuela 23
PH - Filippine 22
SA - Arabia Saudita 20
CH - Svizzera 18
LT - Lituania 18
CZ - Repubblica Ceca 16
MY - Malesia 16
CL - Cile 15
AE - Emirati Arabi Uniti 14
IR - Iran 14
EG - Egitto 13
IE - Irlanda 13
AU - Australia 12
KE - Kenya 11
CR - Costa Rica 10
PY - Paraguay 10
KZ - Kazakistan 9
PE - Perù 9
RO - Romania 9
TN - Tunisia 9
IL - Israele 8
MD - Moldavia 8
AZ - Azerbaigian 7
BO - Bolivia 7
ET - Etiopia 7
LB - Libano 7
OM - Oman 7
JO - Giordania 6
UY - Uruguay 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AL - Albania 5
BB - Barbados 5
DZ - Algeria 5
GR - Grecia 5
KR - Corea 5
NG - Nigeria 5
NO - Norvegia 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
BY - Bielorussia 4
JM - Giamaica 4
NI - Nicaragua 4
NP - Nepal 4
SN - Senegal 4
DK - Danimarca 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
MN - Mongolia 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
AO - Angola 2
BH - Bahrain 2
BJ - Benin 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
PR - Porto Rico 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
Totale 25.376
Città #
Singapore 1.502
Ashburn 1.099
Woodbridge 1.029
Fairfield 917
Chandler 732
San Jose 727
Jacksonville 715
Houston 656
Beijing 570
Santa Clara 510
Hong Kong 492
Wilmington 377
Ann Arbor 375
Seattle 366
Hangzhou 326
Cambridge 292
Milan 290
New York 263
Ho Chi Minh City 246
Rome 224
Munich 214
Izmir 213
Nanjing 189
Los Angeles 182
Dallas 166
Tokyo 148
Princeton 146
Helsinki 138
Hanoi 137
Boardman 125
Lauterbourg 115
Warsaw 103
Addison 99
São Paulo 86
Shenyang 83
San Diego 79
The Dalles 71
Shanghai 70
Mexico City 67
Buffalo 65
Orem 63
Nanchang 62
Dearborn 61
Turku 57
Ferrara 54
Hebei 52
Naples 51
Bologna 49
Turin 48
Hefei 45
Toronto 45
Chennai 43
Changsha 42
Bremen 41
Tianjin 41
Falkenstein 40
London 38
Montreal 37
Verona 37
Brooklyn 35
Frankfurt am Main 35
Vienna 35
Denver 34
Jiaxing 34
Bari 33
Falls Church 33
Florence 33
Haiphong 32
Norwalk 30
San Mateo 30
Council Bluffs 29
Da Nang 28
Rio de Janeiro 28
Johannesburg 27
Kunming 27
Manchester 27
Bangkok 26
Mountain View 26
Palermo 26
Stockholm 26
Chicago 25
Tashkent 25
Brussels 24
Mumbai 24
Amsterdam 23
Baghdad 23
Moscow 23
Redwood City 23
Augusta 21
Jinan 19
Philadelphia 19
Atlanta 18
Boston 18
Guangzhou 18
Brescia 17
Zhengzhou 17
Brasília 16
Hải Dương 16
Modena 16
Padova 16
Totale 16.145
Nome #
Mutazione Q283P nel gene HFE in un eterozigote C282Y affetto da emocromatosi. 1.622
Associazione tra il polimorfismo c.1298A>C del gene MTHFR (Metilenetetraidrofolato Reduttasi) e l’artrite reumatoide 1.267
Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis 415
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 407
HLA-G molecules are constitutively expressed by synovial fibroblasts and up-modulated in osteoarthritis 319
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 291
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 247
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 246
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 244
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 242
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes 238
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 235
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 233
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 231
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 222
Emerging topics and new perspectives on HLA-G 218
The antibiotic polymyxin B modulates P2X7 receptor function 214
Reduced production of anti-inflammatory soluble HLA-G molecules in styrene exposed workers 214
Analisi del polimorfismo IVS2+4T>C del gene HFE in soggetti con sovraccarico di ferro. 213
A novel mutation of HFE explains the classical phenotype of hereditary hemochromatosis in a C282Y carrier 212
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? 211
Purinoceptor function in the immune system 211
Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease 210
HLA-G expression is a fundamental prerequisite to pregnancy 207
Antigenes sHLA-G et polypose naso-sinusienne. 205
The antibiotic polymyxin B modulates P2X7 receptor function 203
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 198
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 197
Antigeni HLA e livelli sierici di HLA solubile nella malattia di Meniere 195
The c.1298A>C polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) gene is risk factor for Rheumatoid Arthritis 190
CYTOLYTIC P2X PURINOCEPTORS 188
Basal production of soluble HLA-G molecules by peripheral blood monocytes in patients with diisocyanate-induced asthma. 184
In vitro studies during long-term oral administration of specific transfer factor 183
Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? 180
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease 180
Human leukocyte antigen-A, -B, -C and -DR alleles and soluble human leukocyte antigen class I serum level in Meniere's disease. 178
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 177
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 176
Role of protein kinase C in the phosphatidylserine-induced inhibition of DNA synthesis in blood mononuclear cells 175
Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients 173
Programmable interactions of functionalized single bioparticles in a dielectrophoresis-based microarray chip. 171
Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in Ulcerative Colitis and Crohn's disease: a non invasive diagnostic tools? 171
Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients. 170
Utilizzo delle MSCs nel controllo del rigetto dei trapianti 169
The HLA-G genotype is associated with IL-10 levels in activated PBMCs 168
Comment on "Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: Generation of IL-10 and induction of regulatory T cells" 167
P2 purinoceptors in the immune system 167
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Preliminary report 167
Allergic women have reduced sHLA-G plasma levels at delivery 166
Extarcellular ATP triggers IL-1beta release by activating the purinergic P2Z receptor of human macrophages 166
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 165
Farmacogenetica dei taxani nel trattamento del carcinoma mammario: possibile ruolo nell’identificazione del rischio di tossicità. 164
HLA B51 antigen associated with neutrophil hyper-reactivity 164
Anti HLA class I monoclonal antibody effect on PKC kinetics in PHA activated human peripheral blood mononuclear and E+ cells 162
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 161
A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells 160
MICA exon 5 microsatellite typing by DNA heteroduplex analysis: a new polymorphism in the transmembrane region 160
Analisi dei genotipi ed aplotipi HFE nella popolazione Ferrarese 158
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II 158
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma. 158
HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy 158
Increased production of soluble HLA-G molecules in stimulated peripheral blood mononuclear cells following extracorporeal photopheresis. Is it a mechanism involved in the therapeutic effect of the procedure? 157
Production of sHLA-G molecules by “in vitro” matured cumulus-oocyte complex 157
P2X7: a novel growth-stimulating receptor in B lymphoblastoid cells 155
Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression 155
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico, trattamenti e malattia. 155
Transfer factor in chronic mucocutaneous candidiasis 154
Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor 154
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico e malattia. 154
An anti-HLA class I monoclonal antibody alters the progression in the cell cycle of phytohemagglutinin-activated human T lymphocytes 154
New insights into HLA-G and inflammatory diseases 152
Multipotent stromal cells skew monocytes towards an anti-inflammatory function: A role for HLA-G molecules 151
Frequenze genotipiche ed aplotipiche HFE nella popolazione della Provincia di Ferrara 149
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 149
Association between MTHFR C.1298A > C polymorphism in the methylene-tetrahydrofolate (MTHFR) gene and increased risk for rheumatoid arthritis 148
Associazione tra HLA-G e Lupus Eritematoso Sistemico. 148
Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease? 147
The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients 147
Ruolo dell’HLA-G nel mantenimento del privilegio immune dell’occhio. 145
Ruolo farmacogenetico del polimorfismo HLA-G 14bp nella risposta alla terapia con Methotrexate nell’artrite reumatoide. 145
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma 142
Antibody-antigen interactions in dielectrophoresis buffers for cell manipulation on dielectrophoresis-based Lab-on-chip devices. 141
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 141
Nucleotide receptor: an emerging family of regulatory molecules in blood cells 140
Il ruolo del polimorfismo HLA-G 14bp nell'invecchiamento. 139
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 138
Mouse dendritic cells express the P2X7 purinergic receptor: Characterization and possible participation in antigen presentation 137
Implication of immunosoppressive molecules during human oocyte maturation 135
Programmable binding of single microspheres to single target tumor cells using a dielectrophoresis (DEP) based “lab-on-a-chip” array. 133
In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment 128
Can HLA-G predict disease course in rheumatoid arthritis patients? 128
Presenza di molecole solubili HLA-G nel plasma da cordone ombelicale: un possibile marcatore di tolerogenicità? 127
The possible role of HLA-G molecules in human oocyte/embryo secretome 126
Serological and molecular HLA typing in Italian Behcet's patients: significant association to B51-DR5-DQw3 haplotype 125
A simple method to identify bone marrow mesenchymal stromal cells with a high immunosuppressive potential 125
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 124
HLA-G expression and regulation in early embryos 124
HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. 122
Una nuova mutazione del gene HFE in un eterozigote C282Y con emocromatosi. 120
Potential role of soluble HLA-G molecules in multiple sclerosis 120
Totale 20.292
Categoria #
all - tutte 95.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 617
Totale 96.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021556 0 0 0 0 0 0 0 0 0 205 275 76
2021/20221.697 61 206 101 86 65 60 79 85 69 134 152 599
2022/20231.903 163 128 67 226 318 255 96 208 207 53 114 68
2023/20241.440 91 143 93 47 107 274 75 80 72 101 93 264
2024/20253.908 172 188 300 212 467 335 186 210 584 385 495 374
2025/20268.216 912 437 741 1.091 1.279 618 1.049 430 806 853 0 0
Totale 25.569